Identification and Functional Characterization of Novel Genetic Variations in the OCTN1 Promoter.
10.4196/kjpp.2014.18.2.169
- Author:
Hyo Jin PARK
1
;
Ji Ha CHOI
Author Information
1. Department of Pharmacology, Tissue Injury Defense Research Center, School of Medicine, Ewha Womans University, Seoul 158-710, Korea. jihachoi@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Genetic variation;
NF-Y;
OCTN1;
Promoter;
Transcriptional regulation
- MeSH:
Alleles;
Binding Sites;
Crohn Disease;
DNA;
Genetic Variation*;
Haplotypes;
HCT116 Cells;
Humans;
Luciferases;
Promoter Regions, Genetic;
Transcription Factors
- From:The Korean Journal of Physiology and Pharmacology
2014;18(2):169-175
- CountryRepublic of Korea
- Language:English
-
Abstract:
Human organic cation/carnitine transporter 1 (OCTN1) plays an important role in the transport of drugs and endogenous substances. It is known that a missense variant of OCTN1 is significantly associated with Crohn's disease susceptibility. This study was performed to identify genetic variants of the OCTN1 promoter in Korean individuals and to determine their functional effects. First, the promoter region of OCTN1 was directly sequenced using genomic DNA samples from 48 healthy Koreans. OCTN1 promoter activity was then measured using a luciferase reporter assay in HCT-116 cells. Seven variants of the OCTN1 promoter were identified, two of which were novel. There were also four major OCTN1 promoter haplotypes. Three haplotypes (H1, H3, and H4) showed decreased transcriptional activity, which was reduced by 22.9%, 23.0%, and 44.6%, respectively (p<0.001), compared with the reference haplotype (H2). Transcription factor binding site analyses and gel shift assays revealed that NF-Y could bind to the region containing g.-1875T>A, a variant present in H3, and that the binding affinity of NF-Y was higher for the g.-1875T allele than for the g.-1875A allele. NF-Y could also repress OCTN1 transcription. These data suggest that three OCTN1 promoter haplotypes could regulate OCTN1 transcription. To our knowledge, this is the first study to identify functional variants of the OCTN1 promoter.
